A research study, in which a designated scrutiny was performed regarding mTOR, showed that nearly 2000 sarcomas exhibited overexpression of mTOR which confirms the critical role of AKT/mTOR pathway in GCTB patients at clinical level. The gene discussed is MTOR; the disease is sarcoma.